Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

GoBroad Healthcare, a Hillhouse Company, Starts Construction of Beijing Research Hospital

publication date: Mar 30, 2020

GoBroad Healthcare Group has broken ground for a Beijing 500-bed research hospital in Life Science Park, a section of Future Science Park in Beijing's Changping district. The project is funded by Hillhouse Capital, a Beijing VC/PE company, and its medical research arm, GoBroad Healthcare Group, along with the government of Changping district. Upon completion, the 100,000-square meter facility will implement translational medicine research, with the goal of reducing the time to market for new drugs. GoBroad described its purpose as forming a closed-loop system that will tie in with Hillhouse's pharma investments. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital